Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
Part of paid clinical trials in Berkeley, California.
- Sponsor
- Sebela Women's Health Inc.
- Study ID
- NCT04457076
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Contraception
- Women at Risk for Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- LevoCept — DRUGLevonorgestrel-Releasing Intrauterine System
Study Details
To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- May 2025
- Primary completion
- Jun 1, 2030
- Completion
- Jun 1, 2032
Study Design
- Enrollment
- 1,525 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: LevoCeptLevoCept™ Intrauterine Contraceptive
Primary Outcome Measure
Contraceptive efficacy through 3 years of use as calculated by the Pearl Index [ Time Frame: through 3 years of use ]
Locations (27)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Essential Access Health-Berkeley | Berkeley | California | 94710 | Fung Lam, MD (PRINCIPAL_INVESTIGATOR) |
| Essential Access Health-Los Angeles | Los Angeles | California | 90010 | Anita Nelson, MD (PRINCIPAL_INVESTIGATOR) |
| University of California Davis Health System Department of Obstetrics and Gynecology | Sacramento | California | 95817 | Mitchell Creinin, MD (PRINCIPAL_INVESTIGATOR) |
| Women's Health Care Research | San Diego | California | 92111 | Rovena Reagan, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Medical Center for Clinical Research | San Diego | California | 92108 | Denis Tarakjian, MD (PRINCIPAL_INVESTIGATOR) |
| Stanford University, Medical Center, Obstetrics and Gynecolocy | Stanford | California | 94305 | Paul Blumenthal, MD (PRINCIPAL_INVESTIGATOR) |
| University Of Colorado Department of Obstetrics & Gyncology | Aurora | Colorado | 80045 | - |
| Emory University School of Medicine Gynecology/Obstetrics | Atlanta | Georgia | 30308 | Tiffany Hailstorks, MD (PRINCIPAL_INVESTIGATOR) |
| Soapstone Center for Clinical Research | Decatur | Georgia | 30034 | Sonya Marks, MD (PRINCIPAL_INVESTIGATOR) |
| University of Hawaii | Honolulu | Hawaii | 96826 | Bliss Kaneshiro, MD (PRINCIPAL_INVESTIGATOR) |
| IU Health University Hospital | Indianapolis | Indiana | 46202 | Jeffrey Peipert, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Planned Parenthood North Central States | Minneapolis | Minnesota | 55408 | Christy Boraas, MD (PRINCIPAL_INVESTIGATOR) |
| Planned Parenthood of the St. Louis Region and Southwest Missouri | Manchester | Missouri | 63088 | - |
| Rex Garn Mabey Jr., MD | Las Vegas | Nevada | 89128 | - |
| Columbia University Medical Center | New York | New York | 10032 | - |
| University of Cincinnati/Reproductive Medicine Research | Cincinnati | Ohio | 45267 | - |
| Ohio State University | Columbus | Ohio | 43209 | - |
| The Ohio State University Ob/Gyn Research Office | Columbus | Ohio | 43210 | - |
| Oregon Health & Science University | Portland | Oregon | 97239 | - |
| Clinical Research of Philadelphia, LLC | Philadelphia | Pennsylvania | 19114 | - |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| Magee-Womens Hospital, Center for Family Planning Research | Pittsburgh | Pennsylvania | 15213 | - |
| Advances In Health | Houston | Texas | 77030 | - |
| University of Utah Healthcare Health Sciences Center | Salt Lake City | Utah | 84132 | - |
| Eastern Virginia Medical | Norfolk | Virginia | 23507 | - |
| Tidewater Physicians for Women | Norfolk | Virginia | 23502 | - |
| Seattle Women's: Health, Research, Gynecology | Seattle | Washington | 98105 | - |
Find similar trials in Berkeley, CA
By research site
Essential Access Health-Berkeley· Berkeley, CAEssential Access Health-Los Angeles· Los Angeles, CAUniversity of California Davis Health System Department of Obstetrics and Gynecology· Sacramento, CAWomen's Health Care Research· San Diego, CAWR-Medical Center for Clinical Research· San Diego, CAStanford University, Medical Center, Obstetrics and Gynecolocy· Stanford, CA
Related Studies
- Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum PeriodRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Etonogestrel Implant as Emergency ContraceptionPHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day StartPHASE4 · Recruiting · University of Utah · San Jose, California
- Endometrial Biopsy in Progestin Contraceptive UsersEARLY_PHASE1 · Recruiting · Oregon Health and Science University · Portland, Oregon